On November 9, 2022 Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, reported that management will participate in the following upcoming investor conferences (Press release, Cogent Biosciences, NOV 9, 2022, View Source [SID1234623527]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies London Healthcare Conference – Wednesday, November 16, 2022 at 11:30 a.m. GMT (6:30 a.m. ET)
Piper Sandler 34th Annual Healthcare Conference – Wednesday, November 30, 2022 at 11:00 a.m. ET
A live webcast of each event can be accessed on the Investors & Media page of Cogent’s website at View Source A replay of the webcasts will be available approximately two hours after the completion of the events and will be archived for up to 30 days following each presentation.